Nanopore develops real-time, scalable sequencing systems that analyze single molecules using proprietary nanopore-based technology. Its solutions enable rapid DNA/RNA sequencing, portable field-based diagnostics, and advanced molecular analytics.
Nanopore supports customers in genomics, life sciences, infectious disease monitoring, and environmental research. The company continues to expand its technology platform to provide faster, cost-efficient sequencing systems with integrated software for real-time insights.
What Is Nanopore and What Does It Do?
Nanopore, founded in 2005 by Gordon Sanghera and Hagan Bayley, is an Oxford-based (United Kingdom) genomics and molecular analysis company.
It develops nanopore-based electronic systems capable of analyzing DNA, RNA, and proteins using real-time sequencing technology. The company also produces reagents, microfluidic preparation instruments, and custom software for instant data interpretation.
Nanopore employs 705 employees. Its platform is widely used across research laboratories, biotech companies, healthcare institutions, and government agencies for rapid diagnostics and high-throughput sequencing applications.
How Much Funding Has Nanopore Raised?
1. Post IPO
- Amount Raised: $64.2M
- Investors: Novo Holdings
2. Post IPO
- Amount Raised: $84.5M
- Investors: BioMérieux
3. Series H
- Amount Raised: $270M
- Investors: M&G, Temasek, Wellington, Nikon
Total Funding Raised: $1.26 Billion
Latest Funding Date: August 2024
Key Investors
1. Wellington
- Details: A leading global investment manager backing growth-stage technology and life sciences companies.
- Investment Focus Areas: Biotechnology, genomics, therapeutics.
- Notable Investments: Moderna, Tempus, Nanopore.
2. Adage Capital Management
- Details: A hedge fund investing in public and private companies across healthcare and technology.
- Investment Focus Areas: Life sciences, diagnostics, biotech.
- Notable Investments: Moderna, Illumina, Editas Medicine.
3. Novo Holdings
- Details: A major life sciences investor supporting global biotech and healthcare companies.
- Investment Focus Areas: Genomics, therapeutics, diagnostics.
- Notable Investments: Novozymes, Exscientia, Nanopore.
4. Temasek
- Details: A global investment company with strong exposure to technology and healthcare.
- Investment Focus Areas: Deep tech, biotech, consumer tech.
- Notable Investments: Gojek, BioNTech, Vertex.
5. BioMérieux
- Details: A global leader in in-vitro diagnostics investing in advanced diagnostic technologies.
- Investment Focus Areas: Molecular diagnostics, infectious disease testing.
- Notable Investments: Specific notable investments not publicly disclosed.
Where Is Nanopore’s Headquarters?
Nanopore is headquartered in Oxford, United Kingdom, a global hub for biotechnology, clinical research, university collaborations, and scientific innovation, giving the company strong access to research talent and genomic expertise.
What’s Next for Nanopore?
Nanopore aims to expand real-time sequencing into clinical diagnostics, infectious disease monitoring, and population health genomics. With rising adoption across healthcare and research sectors, the company plans to improve accuracy, reduce sequencing costs, and scale its software ecosystem. Strategic partnerships and continued investor support will accelerate global growth.
Get Investor & Funding Insights with TexAu
TexAu helps sales and business teams uncover detailed fundraising information on companies like Nanopore. Use the platform to research investors, track funding rounds, and gather actionable insights to strengthen prospecting and business strategy.
Sign Up for Free on TexAu and start uncovering detailed funding insights that give your business a competitive edge.